Daily Digest Daily Digest — October 20, 2026 Jake Lawy swam the River Tone as a salmon and came out wanting the streetlights off. Brazil's Senate voted 75 to 1 to end the six-day week without cutting pay.
Mauritius The Island That Bent the Curve Mauritius is the first country to show type 2 diabetes falling, from 23.3% in 2009 to 19.9% in 2021, measured by oral glucose tolerance test.
Daily Digest Daily Digest — October 19, 2026 Fillongley knitted an RAF man to slow the cars. He was stolen before breakfast. Antarctic ice cliffs fell faster than the models, then stopped.
Health & Medicine Zero New Lesions, and a Rising Infection Count At 84 weeks, Pasatru showed no new heterotopic bone lesions in adults with FOP, against nine on placebo. Skin infections rose to 78 percent at the higher dose.
Daily Digest Daily Digest — October 18, 2026 Helga Duffy landed at Rendcomb with a Guinness certificate. The 101 crossing has a December date. Indonesia's extreme-poverty share fell from 86 percent to under 4.
Health & Medicine The Cell That Can See Through the Disguise WEHI researchers report that gamma delta T cells can recognise small cell lung cancer that hides from other immune cells. No new drug was approved.
Daily Digest Daily Digest — October 17, 2026 Brazil recorded 3,335 square kilometres of Amazon clearance, the lowest since 1988. Sixty-nine countries voted to end the leap second. Six patients still had a vision gain.
Health & Medicine Europe Backs a Weekly Shot. The Commission Has Not Signed. Europe's drug committee backed once-weekly navepegritide for children with achondroplasia. Growth velocity rose 1.49 centimetres a year in 84 children. The Commission has not signed.
Health & Medicine Six Eyes, One Dose, a Cane Left at the Door Three adults treated with OPGx-LCA5 still showed visual gains at 24 months, Opus Genetics said on 15 October. Six patients in total. Phase 3 has not dosed.
pancreatic cancer Europe's Drug Advisers Back a Pancreatic Cancer Pill That Added Months EU drug advisers backed daraxonrasib for metastatic pancreatic cancer after a phase 3 trial reported median survival of 13.2 months versus 6.7 on chemotherapy. The Commission has not yet authorised it.
Daily Digest Daily Digest — October 15, 2026 Eight weeks of hepatitis C pills matched twelve. Mangroves gained 477 square kilometres. Three people are the first human test of partial reprogramming.
hepatitis B No Child in the Survey Had Hepatitis B. Adults Were Not the Question. WHO says Albania and Armenia have reached hepatitis B control targets. No surveyed child aged 6 to 8 tested positive. This is not a claim about adults.
hepatitis C Eight Weeks of Pills Cleared Hepatitis C as Often as Twelve An Indian trial in The Lancet found eight weeks of sofosbuvir-velpatasvir cleared hepatitis C in 98.8 percent of patients without cirrhosis, matching twelve weeks. Guidelines have not changed.
Daily Digest Daily Digest — October 14, 2026 A nurse in Congo Town, a lead-shot vote in Strasbourg, and New Zealand's heaviest insect with four wild generations.
Parkinson's The FDA Approved a Once-Daily Parkinson's Pill Called Juvmo The FDA approved Juvmo, a once-daily D1/D5 pill for Parkinson's. In TEMPO-3 it added 1.7 hours of on-time versus 0.6 on placebo. It is not a cure.
Sierra Leone Sierra Leone's Triple Zero Campaign Is Bending a Death Curve, on Preliminary Data 226 days into Sierra Leone's Triple Zero campaign, a preliminary dashboard shows maternal deaths down about a third. The nurse in Congo Town is the story. The audit is not finished.
Daily Digest Daily Digest — October 13, 2026 Australia's top court blocks a 22-year coal extension, El Salvador eliminates trachoma, and the medicine Nobel honours a light switch for nerve cells.
hereditary angioedema An Oral Drug Eased Hereditary Angioedema Attacks in 1.28 Hours A Lancet phase 3 trial found an oral drug eased hereditary angioedema attacks in a median 1.28 hours, compared with more than 12 hours on placebo.
trachoma El Salvador Eliminates Trachoma, the World's Leading Infectious Cause of Blindness El Salvador is the first Central American country validated by WHO for eliminating trachoma, the world's leading infectious cause of blindness.
Daily Digest Featured Daily Digest — September 21, 2026 A gene therapy restores night vision, Chile eliminates dog rabies, and a record year for renewables.
mental health COMP360 Psilocybin Meets Primary Endpoint in Second Phase 3 Depression Trial Two supervised doses produced a highly significant MADRS drop in treatment-resistant depression.
rabies Chile Becomes First South American Country to Eliminate Dog-Transmitted Rabies WHO validates 50 years without a human case — and the systems that kept it that way.
gene therapy First Successful Pivotal Gene Therapy for a Blinding Eye Disease Restores Night Vision Beacon's laru-zova helped 31% of high-dose patients gain 15 letters of low-light vision — versus none in the control group.
